Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
November 25, 2025
Obesity Video Recap—November 25, 2025
November 25, 2025
Obesity Today—November 25, 2025
November 24, 2025
Hematology Today—November 24, 2025
November 24, 2025
Oncology Video Recap—November 24, 2025
November 24, 2025
Oncology Today—November 24, 2025
November 24, 2025
AI in Healthcare and Digital Health Today—November 24, 2025
November 24, 2025
Lucid Diligence Brief: Aspen Neuroscience $115M Series C
November 23, 2025
Lucid Diligence Brief: Function Health raises $298M Series B at $2.5B
November 21, 2025
Lucid Diligence Brief: WellBeam $10M Series A
November 21, 2025
Public Health Video Recap—November 21, 2025
November 21, 2025